Stay updated on FG-3019 for Diabetic Nephropathy Clinical Trial
Sign up to get notified when there's something new on the FG-3019 for Diabetic Nephropathy Clinical Trial page.

Latest updates to the FG-3019 for Diabetic Nephropathy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe clinical trial record for FG-3019 is displayed, with details about the study design, participant eligibility, treatment groups, outcomes, and locations. The prior 403 error and NIH transition notice are no longer shown.SummaryDifference51%

- Check16 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2; the study record page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA sitewide notice was added announcing an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check30 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedA new Revision: v3.7.0 appears on the page. Numerous historical metadata terms and QC-related notes are removed, reflecting an administrative update to the study record.SummaryDifference17%

Stay in the know with updates to FG-3019 for Diabetic Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 for Diabetic Nephropathy Clinical Trial page.